This article examines an experiment in open innovation applied to scientific research on Type 1 diabetes at Harvard Medical School. In the traditional research process in academic medicine, a single research team typically carries through each stage of the process—from generating the idea to carrying out the research and publishing the results. Harvard Catalyst, a pan-Harvard agency with a mission to speed biomedical research from the lab to patients’ bedsides, modified the traditional grant proposal process as an experiment in bringing greater openness into every stage of research.
To read the full, original article click on this link: Experiments in Open Innovation at Harvard Medical School | MIT Sloan Management Review
